SlideShare a Scribd company logo
Equations of TDM
units converter
1 pound = 0.453 kg
1 inch = 2.54 centimeters
1 foot = 30.48 centimeters
Plasma concentration
Zero Order eq . Frist Order eq .
Log A =
-kt
+ log A
2.3
Half Life =
0.693
k
A = Ao - Ko t
Half life = 0.5 . Ao
Ko
Extraction
E= Cin-Cout
Cin
CrCl =
Ucr . Vcr
Scr
Cockeroft / Gulft eq .
CrCl (male)(ml/min)=
(140 - age ) (w)
(72)(Scr)
CrCl (famale)(ml/min)= CrCl × 0.85
MDRD :
GFR ( ml / min / 1.73
m2
) = 186 × (Scr)
-1.159
× age
-0.203
K =
clT
ClT = Vd . K
Vd
Cp = Cpoe-kt
Jallffe :
CrCl (male)
(ml/min/1.73
m2
BSA)=
98-[0.8(age-20)]
Scr
BSA =
√ht×wt
3600
Ideal Body Weight (male)(kg)=50+[0.9(H-152)]
Ideal Body Weight (famale)(kg)=45.5+[0.9(H-152)]
bwadj =IBW+0.4(ABW-IBW)
Unstable Renal Function :
CrCl(male) = [(293-2.03(age))]×[1.035-0.01685(Scr+Scr2)]+[49(Scr1-Scr2)]
Salazar Eq :
CrCl(male) (ml/dl) =
(137-age)×[(0.285×w)+(12.1×H
2
)]
51×Scr
Salazar Eq :
CrCl(fmale) (ml/dl) =
(146-age)×[(0.287×w)+(9.74×H
2
)]
60×Scr
CrCl(famale) = CrCl(male) × 0.86
CrCl (ml/min) = CrCl . BSA
1.73
Prepared by : Mohammad Matouq Alghamdi
TDM of Aminoglycoside
1. Estimate Creatinine Clearance :
CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min
72×Scr
CrClest(ml/min) = [(140 - age ) BW] .... ml/min
72×Scr
(famale)
(male)
2. Estimate elemination rate constant :
3. Estimate Volume of Distribution :
VD= 0.26 L/kg
VD=0.26[IBM+0.4(TBW-IBW) ..... L/kg in Obese
VD=0.35 ..... L/kg in cystic
VD=(0.26×DBW)+(TBW-DBW) in liver cirrhosis
4.Choose desired stedy state serum concentrations
Css max | Cssmin ug/ml
5. Dosing interval :
interval is rounded to :
6 , 8 , 12 , 18 , 24 , 36 , 48 , 72
mg
mg Computing loding dose if more than 10%
of maintenance dose :
MD
100
LD
T=
[(InCssmax-InCssmin)] + t’ ..... hr
ke
6. Computing maintenance dose :
LD = Ko / ( 1- e
-keT
)
Ko=Cssmax.ke.V[(1-e-kT’
)
]1-e-kt’
Ke = 0.00293(CrCl)+0.014 ..... h-1
t1/2 = 0.693 .... h
ke
In papulation
w
τ
τ
τ
Prepared by : Mohammad Matouq Alghamdi
TDM of Aminoglycoside
1. Estimate Creatinine Clearance :
CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min
72×Scr(famale)
(male)
CrClest(ml/min) = [(140 - age ) BW] ..... ml/min
72×Scr
2. Estimate elemination rate constant :
3. Estimate Volume of Distribution :
VD=
D
× 1-e
-kt’
t’ ke [ Cssmax ( Cssmin × e-ket’
)]
4.Choose desired stedy state serum concentrations
Css max | Cssmin ug/ml
5. Dosing interval :
T=
[(InCssmax-InCssmin)] + t’ ..... hr
ke
LD = Ko / ( 1- e
-keT
)
6. Computing loading dose (LD) :
Ko=Cssmax.ke.V[(1-e-kt
)
]1-e-kt
Ke =
(InCssmax-InCssmin)
..... h-1
T-t’
t1/2 = 0.693 .... h
Ke
In individual
τ
τ
τ
τ
Prepared by : Mohammad Matouq Alghamdi
TDM of Vancomycine
1. Estimate Creatinine Clearance :
CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min
72×Scr(famale)
(male)
CrClest(ml/min) = [(140 - age ) BW] ..... ml/min
72×Scr
4. Estimate elemination rate constant :
3. Estimate Volume of Distribution :
VD= 0.7 .... L/kg
4.Choose desired stedy state serum concentrations
Css max | Cssmin ug/ml
5. Dosing interval :
interval is rounded to :
6 , 8 , 12 , 18 , 24 , 36 , 48 , 72
if CrCl < 60
T=
[(InCssmax-InCssmin)]
..... hr
ke
7. Computing loading dose (LD) :
6. Required dose (D) :
D=Cssmax*V(1-e-keT) .... mg
Ko=Cssmax.V
Ke = Cl / V ( Result*0.06) .... hr
-1
t1/2 = 0.693/ke ... h
2. Estimate clearance of Vancomycine :
Cl = 0.695 ( CrCl / TBW ) + 0.05 ..... ml/min/kg
In papulation
τ
τ
Prepared by : Mohammad Matouq Alghamdi
TDM of Vancomycine
1. Estimate Creatinine Clearance :
CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min
72×Scr(famale)
(male)
CrClest(ml/min) = [(140 - age ) BW] ..... ml/min
72×Scr
2. Estimate elemination rate constant :
3. Estimate Volume of Distribution :
VD= D
Cssmax - Cssmin
4.Choose desired stedy state serum concentrations
Css max | Cssmin ug/ml
5. Dosing interval :
T=
[(InCssmax-InCssmin)]
..... hr
ke
7. Computing loading dose (LD) :
6. Required dose (D) :
D=Cssmax*V(1-e-keT
) .... mg
Ko=Cssmax.V
Ke =
(InCssmax-InCssmin)
..... h-1
T-t’
t1/2 = 0.693 .... h
Ke
In indevidual
mg
L
τ
τ
Prepared by : Mohammad Matouq Alghamdi
Valproic Acid
Age Condition Rang
Adult 7-12 ml/h/kg
Chlidren without drugs induce enzym 10 - 20 ml/h/kg
Chlidren with drugs induce enzym 20-30 ml/h/kg
Liver Cirrosis & Acute hepatits 3 - 4 ml/h/kg
in adult in children ( under 12 y )
Vd = Weight × 0.15 .... L Vd=Weight × 0.2 ...L
1. Estimate Clerance - Rate of Clearce ......... ml / h
2. Volume of Distrbution
3. t2
/1
& Ke
t2
/1
=		 ..... H
4. Compute dose regmint :
D= Css × Cl × τ
F
5. Loading dose in I.V :
LD = Css × V ... mg
• Literature - Based recomended dose :
D= Wight × Rang of dose according to age .... mg
• Seudoliner PK method :
Dnew=
Css new
× D old ... mg
Css old
• PK parametar :
Cl=
F( D )
.... L/hr
	
τ
Css old
0.693×V
Cl
0.693
t2
/1
Ke=		 .... hr-1
In oral Dose F = 1
In Oral sustaind relase F=0.9
if Dose increase Css change %10 - 20 :
(Css = Css new × 0.9) ( Css=Cssnew×0.8)
if Dose Decrease Css change %10 - 20 :
(Css = Css new × 1.1) ( Css=Cssnew×1.2)
For pediatric 10 mg/kg/day
For pediatric ( Take enzyme inducer ) 20 mg/kg/day
For adult 7.5mg/kg/day
For adult ( Take enzyme inducer ) 15mg/kg/day
Prepared by : Mohammad Matouq Alghamdi
Carbamazepine
1. Estimate Carbamazepine dose according to disease state and condotion in patient :
• to compute Css new
Css new=
D new
× Css old ... mg
D old
Conditions Dose
Children under 6 years old 10 - 20 mg/kg/dose
Children 6 - 12 years old 200 mg /day
Adult 400 mg /day
Prepared by : Mohammad Matouq Alghamdi
Digoxin
1. Estimate creatinine clearance :
	 • If not obese  use Cockcroft - Gault equation
	 • If obese  use Salazar & Corcoran
2. Estimate clearance
Cl = 1.303 ( CrCl ) ClNR
	 • ClNR = 40 mL/min since the patient has to mild heart failure
	 • ClNR = 20 mL/min since the patient has to sever heart failure
3. Use average Css equation to compute digoxin (MD) :
D/τ =
Css × Cl .... ug/d
F
	 •Note: the result must × by factor 1.44
4. Compute ( LD ) if needed :
	 • Compute V :
			 (in patient with renal dysfunction (Cl =< 30 mL/min ) :
			V= [ 226 + ( )×( )] ... L
		
			 (in patient ( Cl > 30 mL/min ) :
			V = 7 × kg .. L
	 •LD =
( Css × V )
... ug
		 F
298×CrCl wt
29.1 +CrCl 70
Prepared by : Mohammad Matouq Alghamdi
mmoa92@gmail.com

More Related Content

What's hot

Calcium channel blocker
Calcium channel blockerCalcium channel blocker
Calcium channel blocker
Umang Sharma
 
Guideline for management of gout 2555
Guideline for management of gout 2555Guideline for management of gout 2555
Guideline for management of gout 2555
Utai Sukviwatsirikul
 
Diabetes mellitus amol
Diabetes mellitus amolDiabetes mellitus amol
Diabetes mellitus amol
Dr Amolkumar W Diwan
 
Ueda 2016 4-non pharmacological diabetes management - emad hamed
Ueda 2016 4-non pharmacological diabetes management - emad hamedUeda 2016 4-non pharmacological diabetes management - emad hamed
Ueda 2016 4-non pharmacological diabetes management - emad hamed
ueda2015
 
แผนFenofibrate pdf
แผนFenofibrate pdfแผนFenofibrate pdf
แผนFenofibrate pdf
Thamonwan Theerabunchorn
 
Clinical pharmacokinetics of digoxin
Clinical pharmacokinetics of digoxinClinical pharmacokinetics of digoxin
Clinical pharmacokinetics of digoxin
YOUAN BI BENIET MARIUS
 
Hybrid closed loop insulin delivery system-Artificial Pancreas.
Hybrid closed loop insulin delivery system-Artificial Pancreas.Hybrid closed loop insulin delivery system-Artificial Pancreas.
Hybrid closed loop insulin delivery system-Artificial Pancreas.
Shubham Bhujbal
 
Types of Diabetes
Types of DiabetesTypes of Diabetes
Types of Diabetes
Fatima AlSaadi
 
Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
Jack Frost
 
Pediatric dose from angthong hospital
Pediatric dose from angthong hospital Pediatric dose from angthong hospital
Pediatric dose from angthong hospital
Utai Sukviwatsirikul
 
Clinical Practice Guideline Acne 2010
Clinical Practice Guideline Acne  2010Clinical Practice Guideline Acne  2010
Clinical Practice Guideline Acne 2010
Utai Sukviwatsirikul
 
Insulin pump therapy
Insulin pump therapyInsulin pump therapy
Insulin pump therapy
Dr. Lala Shourav Das
 
Acute Coronary syndrome - Pharmacotherapy
Acute Coronary syndrome - PharmacotherapyAcute Coronary syndrome - Pharmacotherapy
Acute Coronary syndrome - Pharmacotherapy
Areej Abu Hanieh
 
Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors
Philip Vaidyan
 
Insulin pumps
Insulin pumpsInsulin pumps
Insulin pumps
mishka12345
 
19 Insulin Types
19 Insulin Types19 Insulin Types
19 Insulin Types
kdiwavvou
 
Pediatric dosage table ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนัก
Pediatric dosage table   ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนักPediatric dosage table   ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนัก
Pediatric dosage table ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนักAiman Sadeeyamu
 
Clinical Practice Guidelines for Traumatic Brain Injury 2556
Clinical Practice Guidelines for Traumatic Brain Injury 2556Clinical Practice Guidelines for Traumatic Brain Injury 2556
Clinical Practice Guidelines for Traumatic Brain Injury 2556
Utai Sukviwatsirikul
 
Individualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenarioIndividualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenario
Prithvi Puwar
 
Diabetic Nephropathy 1
Diabetic Nephropathy 1Diabetic Nephropathy 1
Diabetic Nephropathy 1
mondy19
 

What's hot (20)

Calcium channel blocker
Calcium channel blockerCalcium channel blocker
Calcium channel blocker
 
Guideline for management of gout 2555
Guideline for management of gout 2555Guideline for management of gout 2555
Guideline for management of gout 2555
 
Diabetes mellitus amol
Diabetes mellitus amolDiabetes mellitus amol
Diabetes mellitus amol
 
Ueda 2016 4-non pharmacological diabetes management - emad hamed
Ueda 2016 4-non pharmacological diabetes management - emad hamedUeda 2016 4-non pharmacological diabetes management - emad hamed
Ueda 2016 4-non pharmacological diabetes management - emad hamed
 
แผนFenofibrate pdf
แผนFenofibrate pdfแผนFenofibrate pdf
แผนFenofibrate pdf
 
Clinical pharmacokinetics of digoxin
Clinical pharmacokinetics of digoxinClinical pharmacokinetics of digoxin
Clinical pharmacokinetics of digoxin
 
Hybrid closed loop insulin delivery system-Artificial Pancreas.
Hybrid closed loop insulin delivery system-Artificial Pancreas.Hybrid closed loop insulin delivery system-Artificial Pancreas.
Hybrid closed loop insulin delivery system-Artificial Pancreas.
 
Types of Diabetes
Types of DiabetesTypes of Diabetes
Types of Diabetes
 
Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
 
Pediatric dose from angthong hospital
Pediatric dose from angthong hospital Pediatric dose from angthong hospital
Pediatric dose from angthong hospital
 
Clinical Practice Guideline Acne 2010
Clinical Practice Guideline Acne  2010Clinical Practice Guideline Acne  2010
Clinical Practice Guideline Acne 2010
 
Insulin pump therapy
Insulin pump therapyInsulin pump therapy
Insulin pump therapy
 
Acute Coronary syndrome - Pharmacotherapy
Acute Coronary syndrome - PharmacotherapyAcute Coronary syndrome - Pharmacotherapy
Acute Coronary syndrome - Pharmacotherapy
 
Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors Sodium glucose co transporter( SGLT2) Inhibitors
Sodium glucose co transporter( SGLT2) Inhibitors
 
Insulin pumps
Insulin pumpsInsulin pumps
Insulin pumps
 
19 Insulin Types
19 Insulin Types19 Insulin Types
19 Insulin Types
 
Pediatric dosage table ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนัก
Pediatric dosage table   ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนักPediatric dosage table   ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนัก
Pediatric dosage table ขนาดการใช้ในเด็กแบ่งตามอายุ+น้ำหนัก
 
Clinical Practice Guidelines for Traumatic Brain Injury 2556
Clinical Practice Guidelines for Traumatic Brain Injury 2556Clinical Practice Guidelines for Traumatic Brain Injury 2556
Clinical Practice Guidelines for Traumatic Brain Injury 2556
 
Individualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenarioIndividualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenario
 
Diabetic Nephropathy 1
Diabetic Nephropathy 1Diabetic Nephropathy 1
Diabetic Nephropathy 1
 

Viewers also liked

Bronchiolitis | Case Study
Bronchiolitis | Case StudyBronchiolitis | Case Study
Bronchiolitis | Case Study
Mohammad Alghamdi
 
Bronchiolitis overview
Bronchiolitis   overviewBronchiolitis   overview
Bronchiolitis overview
Sid Kaithakkoden
 
2013.09.29 lect critconfenkre22102013 2
2013.09.29   lect critconfenkre22102013 22013.09.29   lect critconfenkre22102013 2
2013.09.29 lect critconfenkre22102013 2Sébastien MARTIN
 
La bronchiolite du nourrisson
La bronchiolite du nourrissonLa bronchiolite du nourrisson
La bronchiolite du nourrisson
François-Régis Sarhan
 
Asthma
AsthmaAsthma
La bronchiolite aigue
La bronchiolite aigueLa bronchiolite aigue
La bronchiolite aigueHaythem Chiha
 
Bronchiolitis 2
Bronchiolitis 2Bronchiolitis 2
Bronchiolitis 2
Dewie Yunianti
 
Introduction to Hematology and Anemia
Introduction to Hematology and AnemiaIntroduction to Hematology and Anemia
Introduction to Hematology and Anemia
The Medical Post
 
Common neonatal disorders
Common neonatal disordersCommon neonatal disorders
Common neonatal disorders
Kiran
 
Neonatal Respiratory Distress
Neonatal Respiratory DistressNeonatal Respiratory Distress
Neonatal Respiratory Distress
. .
 
bronchiolitis in paediatrics
bronchiolitis in paediatricsbronchiolitis in paediatrics
bronchiolitis in paediatrics
meducationdotnet
 
Acute bronchiolitis ppt
Acute bronchiolitis pptAcute bronchiolitis ppt
Acute bronchiolitis ppt
mohamed abdelaziz Ali
 
sampling ppt
sampling pptsampling ppt
sampling ppt
Swati Luthra
 
Beautiful Landscapes
Beautiful LandscapesBeautiful Landscapes
Beautiful Landscapes
Manuela Szekely
 
Pneumonia Diagnosis and treatment
Pneumonia Diagnosis and treatmentPneumonia Diagnosis and treatment
Pneumonia Diagnosis and treatment
Dr. Vijit Agrawal, B. Pharm., Pharm. D.
 
neonatal Jaundice
neonatal Jaundiceneonatal Jaundice
neonatal Jaundice
Hardi Hussein
 

Viewers also liked (17)

Bronchiolitis | Case Study
Bronchiolitis | Case StudyBronchiolitis | Case Study
Bronchiolitis | Case Study
 
Bronchiolitis overview
Bronchiolitis   overviewBronchiolitis   overview
Bronchiolitis overview
 
2013.09.29 lect critconfenkre22102013 2
2013.09.29   lect critconfenkre22102013 22013.09.29   lect critconfenkre22102013 2
2013.09.29 lect critconfenkre22102013 2
 
La bronchiolite du nourrisson
La bronchiolite du nourrissonLa bronchiolite du nourrisson
La bronchiolite du nourrisson
 
Bronchiolite
BronchioliteBronchiolite
Bronchiolite
 
Asthma
AsthmaAsthma
Asthma
 
La bronchiolite aigue
La bronchiolite aigueLa bronchiolite aigue
La bronchiolite aigue
 
Bronchiolitis 2
Bronchiolitis 2Bronchiolitis 2
Bronchiolitis 2
 
Introduction to Hematology and Anemia
Introduction to Hematology and AnemiaIntroduction to Hematology and Anemia
Introduction to Hematology and Anemia
 
Common neonatal disorders
Common neonatal disordersCommon neonatal disorders
Common neonatal disorders
 
Neonatal Respiratory Distress
Neonatal Respiratory DistressNeonatal Respiratory Distress
Neonatal Respiratory Distress
 
bronchiolitis in paediatrics
bronchiolitis in paediatricsbronchiolitis in paediatrics
bronchiolitis in paediatrics
 
Acute bronchiolitis ppt
Acute bronchiolitis pptAcute bronchiolitis ppt
Acute bronchiolitis ppt
 
sampling ppt
sampling pptsampling ppt
sampling ppt
 
Beautiful Landscapes
Beautiful LandscapesBeautiful Landscapes
Beautiful Landscapes
 
Pneumonia Diagnosis and treatment
Pneumonia Diagnosis and treatmentPneumonia Diagnosis and treatment
Pneumonia Diagnosis and treatment
 
neonatal Jaundice
neonatal Jaundiceneonatal Jaundice
neonatal Jaundice
 

Recently uploaded

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 

Recently uploaded (20)

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 

The Most Equations use for TDM

  • 1. Equations of TDM units converter 1 pound = 0.453 kg 1 inch = 2.54 centimeters 1 foot = 30.48 centimeters Plasma concentration Zero Order eq . Frist Order eq . Log A = -kt + log A 2.3 Half Life = 0.693 k A = Ao - Ko t Half life = 0.5 . Ao Ko Extraction E= Cin-Cout Cin CrCl = Ucr . Vcr Scr Cockeroft / Gulft eq . CrCl (male)(ml/min)= (140 - age ) (w) (72)(Scr) CrCl (famale)(ml/min)= CrCl × 0.85 MDRD : GFR ( ml / min / 1.73 m2 ) = 186 × (Scr) -1.159 × age -0.203 K = clT ClT = Vd . K Vd Cp = Cpoe-kt Jallffe : CrCl (male) (ml/min/1.73 m2 BSA)= 98-[0.8(age-20)] Scr BSA = √ht×wt 3600 Ideal Body Weight (male)(kg)=50+[0.9(H-152)] Ideal Body Weight (famale)(kg)=45.5+[0.9(H-152)] bwadj =IBW+0.4(ABW-IBW) Unstable Renal Function : CrCl(male) = [(293-2.03(age))]×[1.035-0.01685(Scr+Scr2)]+[49(Scr1-Scr2)] Salazar Eq : CrCl(male) (ml/dl) = (137-age)×[(0.285×w)+(12.1×H 2 )] 51×Scr Salazar Eq : CrCl(fmale) (ml/dl) = (146-age)×[(0.287×w)+(9.74×H 2 )] 60×Scr CrCl(famale) = CrCl(male) × 0.86 CrCl (ml/min) = CrCl . BSA 1.73 Prepared by : Mohammad Matouq Alghamdi
  • 2. TDM of Aminoglycoside 1. Estimate Creatinine Clearance : CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min 72×Scr CrClest(ml/min) = [(140 - age ) BW] .... ml/min 72×Scr (famale) (male) 2. Estimate elemination rate constant : 3. Estimate Volume of Distribution : VD= 0.26 L/kg VD=0.26[IBM+0.4(TBW-IBW) ..... L/kg in Obese VD=0.35 ..... L/kg in cystic VD=(0.26×DBW)+(TBW-DBW) in liver cirrhosis 4.Choose desired stedy state serum concentrations Css max | Cssmin ug/ml 5. Dosing interval : interval is rounded to : 6 , 8 , 12 , 18 , 24 , 36 , 48 , 72 mg mg Computing loding dose if more than 10% of maintenance dose : MD 100 LD T= [(InCssmax-InCssmin)] + t’ ..... hr ke 6. Computing maintenance dose : LD = Ko / ( 1- e -keT ) Ko=Cssmax.ke.V[(1-e-kT’ ) ]1-e-kt’ Ke = 0.00293(CrCl)+0.014 ..... h-1 t1/2 = 0.693 .... h ke In papulation w τ τ τ Prepared by : Mohammad Matouq Alghamdi
  • 3. TDM of Aminoglycoside 1. Estimate Creatinine Clearance : CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min 72×Scr(famale) (male) CrClest(ml/min) = [(140 - age ) BW] ..... ml/min 72×Scr 2. Estimate elemination rate constant : 3. Estimate Volume of Distribution : VD= D × 1-e -kt’ t’ ke [ Cssmax ( Cssmin × e-ket’ )] 4.Choose desired stedy state serum concentrations Css max | Cssmin ug/ml 5. Dosing interval : T= [(InCssmax-InCssmin)] + t’ ..... hr ke LD = Ko / ( 1- e -keT ) 6. Computing loading dose (LD) : Ko=Cssmax.ke.V[(1-e-kt ) ]1-e-kt Ke = (InCssmax-InCssmin) ..... h-1 T-t’ t1/2 = 0.693 .... h Ke In individual τ τ τ τ Prepared by : Mohammad Matouq Alghamdi
  • 4. TDM of Vancomycine 1. Estimate Creatinine Clearance : CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min 72×Scr(famale) (male) CrClest(ml/min) = [(140 - age ) BW] ..... ml/min 72×Scr 4. Estimate elemination rate constant : 3. Estimate Volume of Distribution : VD= 0.7 .... L/kg 4.Choose desired stedy state serum concentrations Css max | Cssmin ug/ml 5. Dosing interval : interval is rounded to : 6 , 8 , 12 , 18 , 24 , 36 , 48 , 72 if CrCl < 60 T= [(InCssmax-InCssmin)] ..... hr ke 7. Computing loading dose (LD) : 6. Required dose (D) : D=Cssmax*V(1-e-keT) .... mg Ko=Cssmax.V Ke = Cl / V ( Result*0.06) .... hr -1 t1/2 = 0.693/ke ... h 2. Estimate clearance of Vancomycine : Cl = 0.695 ( CrCl / TBW ) + 0.05 ..... ml/min/kg In papulation τ τ Prepared by : Mohammad Matouq Alghamdi
  • 5. TDM of Vancomycine 1. Estimate Creatinine Clearance : CrClest(ml/min) = [(140 - age ) BW]*0.85 .... ml/min 72×Scr(famale) (male) CrClest(ml/min) = [(140 - age ) BW] ..... ml/min 72×Scr 2. Estimate elemination rate constant : 3. Estimate Volume of Distribution : VD= D Cssmax - Cssmin 4.Choose desired stedy state serum concentrations Css max | Cssmin ug/ml 5. Dosing interval : T= [(InCssmax-InCssmin)] ..... hr ke 7. Computing loading dose (LD) : 6. Required dose (D) : D=Cssmax*V(1-e-keT ) .... mg Ko=Cssmax.V Ke = (InCssmax-InCssmin) ..... h-1 T-t’ t1/2 = 0.693 .... h Ke In indevidual mg L τ τ Prepared by : Mohammad Matouq Alghamdi
  • 6. Valproic Acid Age Condition Rang Adult 7-12 ml/h/kg Chlidren without drugs induce enzym 10 - 20 ml/h/kg Chlidren with drugs induce enzym 20-30 ml/h/kg Liver Cirrosis & Acute hepatits 3 - 4 ml/h/kg in adult in children ( under 12 y ) Vd = Weight × 0.15 .... L Vd=Weight × 0.2 ...L 1. Estimate Clerance - Rate of Clearce ......... ml / h 2. Volume of Distrbution 3. t2 /1 & Ke t2 /1 = ..... H 4. Compute dose regmint : D= Css × Cl × τ F 5. Loading dose in I.V : LD = Css × V ... mg • Literature - Based recomended dose : D= Wight × Rang of dose according to age .... mg • Seudoliner PK method : Dnew= Css new × D old ... mg Css old • PK parametar : Cl= F( D ) .... L/hr τ Css old 0.693×V Cl 0.693 t2 /1 Ke= .... hr-1 In oral Dose F = 1 In Oral sustaind relase F=0.9 if Dose increase Css change %10 - 20 : (Css = Css new × 0.9) ( Css=Cssnew×0.8) if Dose Decrease Css change %10 - 20 : (Css = Css new × 1.1) ( Css=Cssnew×1.2) For pediatric 10 mg/kg/day For pediatric ( Take enzyme inducer ) 20 mg/kg/day For adult 7.5mg/kg/day For adult ( Take enzyme inducer ) 15mg/kg/day Prepared by : Mohammad Matouq Alghamdi
  • 7. Carbamazepine 1. Estimate Carbamazepine dose according to disease state and condotion in patient : • to compute Css new Css new= D new × Css old ... mg D old Conditions Dose Children under 6 years old 10 - 20 mg/kg/dose Children 6 - 12 years old 200 mg /day Adult 400 mg /day Prepared by : Mohammad Matouq Alghamdi
  • 8. Digoxin 1. Estimate creatinine clearance : • If not obese  use Cockcroft - Gault equation • If obese  use Salazar & Corcoran 2. Estimate clearance Cl = 1.303 ( CrCl ) ClNR • ClNR = 40 mL/min since the patient has to mild heart failure • ClNR = 20 mL/min since the patient has to sever heart failure 3. Use average Css equation to compute digoxin (MD) : D/τ = Css × Cl .... ug/d F •Note: the result must × by factor 1.44 4. Compute ( LD ) if needed : • Compute V : (in patient with renal dysfunction (Cl =< 30 mL/min ) : V= [ 226 + ( )×( )] ... L (in patient ( Cl > 30 mL/min ) : V = 7 × kg .. L •LD = ( Css × V ) ... ug F 298×CrCl wt 29.1 +CrCl 70 Prepared by : Mohammad Matouq Alghamdi mmoa92@gmail.com